Biogen Inc (BIIB)
231.69
-2.15
(-0.92%)
USD |
NASDAQ |
Jun 14, 16:00
231.66
-0.03
(-0.01%)
After-Hours: 20:00
Biogen EPS Diluted (Annual): 7.97 for Dec. 31, 2023
EPS Diluted (Annual) Chart
Historical EPS Diluted (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 7.97 |
December 31, 2022 | 20.87 |
December 31, 2021 | 10.40 |
December 31, 2020 | 24.80 |
December 31, 2019 | 31.42 |
December 31, 2018 | 21.58 |
December 31, 2017 | 11.92 |
December 31, 2016 | 16.93 |
December 31, 2015 | 15.34 |
December 31, 2014 | 12.37 |
December 31, 2013 | 7.81 |
December 31, 2012 | 5.76 |
December 31, 2011 | 5.04 |
December 31, 2010 | 3.94 |
December 31, 2009 | 3.35 |
December 31, 2008 | 2.65 |
December 31, 2007 | 1.99 |
December 31, 2006 | 0.63 |
December 31, 2005 | 0.47 |
December 31, 2004 | 0.07 |
Date | Value |
---|---|
December 31, 2003 | -4.92 |
December 31, 2002 | 0.85 |
December 31, 2001 | 1.78 |
December 31, 2000 | 0.72 |
December 31, 1999 | 0.4667 |
December 31, 1998 | 0.30 |
December 31, 1997 | 0.195 |
December 31, 1996 | 0.0917 |
December 31, 1995 | 0.0267 |
December 31, 1994 | -0.025 |
December 31, 1993 | 0.04 |
December 31, 1992 | 0.045 |
December 31, 1991 | 0.0067 |
December 31, 1990 | 0.0033 |
December 31, 1989 | 0.0017 |
December 31, 1988 | -0.0033 |
December 31, 1987 | -0.0433 |
December 31, 1986 | -0.06 |
December 31, 1985 | -0.0433 |
December 31, 1984 | -0.03 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Annual) Range, Past 5 Years
7.97
Minimum
2023
31.42
Maximum
2019
19.09
Average
20.87
Median
2022
EPS Diluted (Annual) Benchmarks
Ionis Pharmaceuticals Inc | -2.56 |
Eli Lilly and Co | 5.80 |
Bristol-Myers Squibb Co | 3.86 |
Regeneron Pharmaceuticals Inc | 34.77 |
Sage Therapeutics Inc | -9.05 |